Table 3 Multivariate analysis of prognostic factors in metastatic gastric cancer patients undergoing resection
From: Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer
Factors | Hazard ratio (95% CI) | P value |
|---|---|---|
Age (years) | ||
> 58/≤58 | 1.47 (1.01–2.13) | 0.045 |
Gender | ||
Male/female | 1.14 (0.80–1.63) | 0.465 |
Albumin (g/dL) | ||
≤ 3 />3 | 1.93 (1.24–3.00) | 0.003 |
Tumor-associated symptoms | ||
Yes/no | 1.04 (0.73–1.47) | 0.837 |
N status | ||
N1/N0 | 0.83 (0.33–2.10) | 0.695 |
N2/N0 | 1.30 (0.56–3.01) | 0.542 |
N3/N0 | 1.16 (0.49–2.72) | 0.740 |
LN ratioa | ||
> 0.58/≤0.58 | 1.47 (1.01–2.15) | 0.047 |
Lymphatic invasion | ||
Yes/no | 1.20 (0.62–2.32) | 0.588 |
Perineural invasion | ||
Yes/no | 1.08 (0.70–1.65) | 0.728 |
Chemotherapy | ||
No/yes | 1.68 (1.19–2.38) | 0.004 |